More than 1.3 million Americans fall victim to medication errors—and, for one Ohio nurse, it's a case of enough is enough. Janeen Jones, BSN, RN, has developed the MagniMed line of lighted magnification systems to make small print on medication labels easier to read.

Drug companies will collectively pay an extra $100 million in annual membership dues to industry group Pharmaceutical Research and Manufacturers of America (PhRMA).

The average monthly premium for the second-lowest cost silver plan on the Healthcare.gov marketplace will go up by 25 percent for 2017, according to HHS, the largest year-over-year jump in prices since the marketplace opened.

Precision biomarkers have been shown to be an effective tool in cancer care, but most evidence comes from clinical trials rather than real patient experiences. Christopher Friese, PhD, RN, of the University of Michigan School of Nursing in Ann Arbor, and colleagues are testing how practicing physicians are using a 21-gene recurrence score (RS) biomarker test in breast cancer patients.

CMS’s star rating system is more about the affluence of patients than quality of care, argued Missouri Health Association CEO Herb Kuhn and Vice President of Research and Analytics Mat Reidhead.

A Washington Post investigation said the Drug Enforcement Administration (DEA) dropped its aggressive efforts against pharmacies, physicians, distributors and manufacturers to curb opioid abuse, mostly thanks to pressure from drug companies.

Preparing patients before surgical procedures with enhanced recovery after surgery (ERAS) programs boosts patient knowledge while reducing recuperation time and decreasing necessary drug intervention, according to the results shown at two different healthcare facilities.

The calls for a government-run insurance option on the Affordable Care Act’s insurance exchanges are being met with resistance from groups that had supported the law.